2023年ASCO乳腺癌治疗进展  

Current progress and advances in breast cancer:Highlights from 2023 ASCO annual meeting

作　　者：徐娇娇 陈占红[2] 王晓稼 Xu Jiaojiao;Chen Zhanhong;Wang Xiaojia(The Second Clinical Medical College,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Breast Oncology,Zhejiang Cancer Hospital,Hangzhou 310005,China)

机构地区：[1]浙江中医药大学第二临床医学院,浙江杭州310053 [2]浙江省肿瘤医院乳腺内科,浙江杭州310005

出　　处：《实用肿瘤杂志》2023年第4期317-323,共7页Journal of Practical Oncology

基　　金：浙江省重点研发计划项目(国际合作技术研发与示范推广项目)(2020C04012)。

摘　　要：2023年美国临床肿瘤学会(American Society of Clinical Oncology,ASCO)年会于当地时间2023年6月2日在美国芝加哥举行。本次大会报道了多项乳腺癌领域的重要研究进展,涵盖了早期辅助治疗、晚期解救治疗与转化性研究等,这些研究结果将对现今乳腺癌诊疗产生实质性的影响,在一些领域将改变临床指南和实践。本文将介绍大会中乳腺癌相关的研究结果,并对部分研究热点展开讨论。The 2023 annual meeting of the American Society of Clinical Oncology(ASCO)was held on June 2nd,2023,in Chicago,USA.This conference reported a number of important studies in the field of breast cancer,covering adjuvant therapy,salvage therapy,translational research,etc.These results will have a substantial impact on the diagnosis and treatment of breast cancer today,and will change clinical recommendations and practice in some areas.This article introduces the research results linked to breast cancer in this conference and discusses some research hotspots.

关 键 词：乳腺癌 美国临床肿瘤学会 2023 

分 类 号：R737.9[医药卫生—肿瘤]